Vimarsana
Biggest News Aggregation in the World

Page 48 - Robert Koch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Koch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Koch Today - Breaking & Trending Today

Ghana joins the world to commemorate World TB Day - Vimarsana News

Ghana joins the world to commemorate World TB Day

Ghana is today joining the rest of the world to commemorate World Tuberculosis (TB) Day as it continues to remain a major public health threat in Ghana and globally. This year’s commemoration is on the theme: “Yes! We Can End TB” According to the World Health Organisation (WHO), TB it…

Evotec SE: Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis - Vimarsana News

Evotec SE: Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis

GRANT FROM THE BILL & MELINDA GATES FOUNDATION SUPPORTS EVOTEC'S EFFORTS TO DISCOVER AND DEVELOP DRUG CANDIDATES FOR A UNIVERSAL, SHORTER, SAFER AND SIMPLER TUBERCULOSIS DRUG REGIMEN AS ONE OF ITS PROGRAMMES

World tuberculosis day Tuberculosis: What is it? - Vimarsana News

World tuberculosis day Tuberculosis: What is it?

The content originally appeared on: News Americas Now Black Immigrant Daily News The content originally appeared on: Antigua News Room “Yes! We can end TB!” ...

The World Health Organization announces an expansion of the plan to eliminate tuberculosis by 2030 - Vimarsana News

The World Health Organization announces an expansion of the plan to eliminate tuberculosis by 2030

A Tuberculosis causes 1.6 million deaths each year It affects millions of people.On the occasion of World Sickness Day, prof The World Health Organization

World Tuberculosis Day: Easing the Continuum of Care Burden - Vimarsana News

World Tuberculosis Day: Easing the Continuum of Care Burden

The Bill & Melinda Gates Medical Research Institute has multiple tuberculosis (TB) therapies and a prophylactic vaccine in development, and its chief medical officer, Michael W. Dunne, MD, remains optimistic long-term about the state of clinical care, especially in low-and-middle-income countries.

Source: ajmc.com